Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

JZZ Technologies, Inc. (JZZI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0018-0.0001 (-5.26%)
At close: 03:55PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0019
Open0.0019
BidN/A x N/A
AskN/A x N/A
Day's Range0.0018 - 0.0019
52 Week Range0.0015 - 0.0247
Volume2,502,260
Avg. Volume9,122,012
Market Cap419,655
Beta (5Y Monthly)-2.19
PE Ratio (TTM)∞
EPS (TTM)0.0000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for JZZI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • JZZ TECHNOLOGIES INC
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    10 hours agoMorningstar
View more
  • Newsfile

    JZZ Technologies, Inc. Expands Active Lifestyle Marketing Data to Include Over Six Million B2B Records

    Anderson, South Carolina--(Newsfile Corp. - August 3, 2022) - JZZ Technologies Inc., (OTC Pink: JZZI) ("JZZ" or the "Company"), a diversified technology company focused on digital media and strategic biotechnology acquisitions related to human life extension, including human longevity, is expanding its data marketing operations beyond the 55+ marketplace to now include over six million B2B marketplace records, including senior management individuals and company CEOs. JZZ Technologies, Inc. has a

  • Newsfile

    JZZ Technologies, Inc. Entering the Lucrative Diabetic Marketing Sector With its Active Lifestyle Nutrition Marketing Offering

    Anderson, South Carolina--(Newsfile Corp. - July 26, 2022) - JZZ Technologies Inc., (OTC Pink: JZZI) ("JZZ" or the "Company"), a diversified technology company focused on digital media and strategic biotechnology acquisitions related to human life extension, including human longevity, is entering the multi-billion-dollar diabetic products and services marketing sector through its Active Lifestyle Nutrition marketing platforms including its DTC (Direct-To-Consumer) database and website.The Compan

  • Newsfile

    JZZ Technologies, Inc. Adds Glutathione Product to its Growing Nutritional Supplements Line at ActiveLifestyleNutrition.com

    Anderson, South Carolina--(Newsfile Corp. - July 21, 2022) - JZZ Technologies Inc., (OTC PINK: JZZI) ("JZZ" or the "Company"), a diversified technology company focused on digital media and strategic biotechnology acquisitions related to human life extension, including human longevity, has begun offering a new formulation of Glutathione supplement through its activelifestylenutrition.com website.Glutathione is a powerful antioxidant made in the body's cells. It is a molecule found naturally in yo

Advertisement
Advertisement